Venus Medtech-B (02500) Sets 31 March 2026 Board Meeting to Approve FY 2025 Results

Bulletin Express

03/19

Venus Medtech (Hangzhou) Inc. (stock code: 02500) has announced that its Board of Directors will convene on 31 March 2026. The meeting’s primary agenda is to review and approve the consolidated annual results for the financial year ended 31 December 2025, followed by the publication of the audited figures.

The session will also address any additional corporate matters deemed necessary. According to the disclosure, the company’s current board comprises three executive directors (Lim Hou-Sen, Liqiao Ma and Meirong Liu), two non-executive directors (Ao Zhang and Wei Wang) and three independent non-executive directors (Ting Yuk Anthony Wu, Chi Wai Suen and John Junhua Gu).

The announcement was authorised for issue by Executive Director Mr Lim Hou-Sen on 19 March 2026 in Hangzhou. No further financial details were provided ahead of the scheduled meeting.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1130710402"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1130710402\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1130710402?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 19:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130710402","market":"us","top_or_hot":-1,"title":"Venus Medtech-B (02500) Sets 31 March 2026 Board Meeting to Approve FY 2025 Results","media":"Bulletin Express","content":"<p>Venus Medtech (Hangzhou) Inc. (stock code: 02500) has announced that its Board of Directors will convene on 31 March 2026. The meeting’s primary agenda is to review and approve the consolidated annual results for the financial year ended 31 December 2025, followed by the publication of the audited figures.</p>\n<p>The session will also address any additional corporate matters deemed necessary. According to the disclosure, the company’s current board comprises three executive directors (Lim Hou-Sen, Liqiao Ma and Meirong Liu), two non-executive directors (Ao Zhang and Wei Wang) and three independent non-executive directors (Ting Yuk Anthony Wu, Chi Wai Suen and John Junhua Gu).</p>\n<p>The announcement was authorised for issue by Executive Director Mr Lim Hou-Sen on 19 March 2026 in Hangzhou. No further financial details were provided ahead of the scheduled meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Venus Medtech-B (02500) Sets 31 March 2026 Board Meeting to Approve FY 2025 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVenus Medtech-B (02500) Sets 31 March 2026 Board Meeting to Approve FY 2025 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-19 19:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Venus Medtech (Hangzhou) Inc. (stock code: 02500) has announced that its Board of Directors will convene on 31 March 2026. The meeting’s primary agenda is to review and approve the consolidated annual results for the financial year ended 31 December 2025, followed by the publication of the audited figures.</p>\n<p>The session will also address any additional corporate matters deemed necessary. According to the disclosure, the company’s current board comprises three executive directors (Lim Hou-Sen, Liqiao Ma and Meirong Liu), two non-executive directors (Ao Zhang and Wei Wang) and three independent non-executive directors (Ting Yuk Anthony Wu, Chi Wai Suen and John Junhua Gu).</p>\n<p>The announcement was authorised for issue by Executive Director Mr Lim Hou-Sen on 19 March 2026 in Hangzhou. No further financial details were provided ahead of the scheduled meeting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02500","symbol_name":"启明医疗-B","start_time":0,"source_url":"","article_id":"1130710402","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130710402","pubTimestamp":1773919343,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Venus Medtech (Hangzhou) Inc. (stock code: 02500) has announced that its Board of Directors will convene on 31 March 2026. The meeting’s primary agenda is to review and approve the consolidated...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02500":"启明医疗-B"},"translate_title":"Venus Medtech-B(02500)定于2026年3月31日召开董事会批准2025财年业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02500":1},"content_text":"Venus Medtech (Hangzhou) Inc. (stock code: 02500) has announced that its Board of Directors will convene on 31 March 2026. The meeting’s primary agenda is to review and approve the consolidated annual results for the financial year ended 31 December 2025, followed by the publication of the audited figures.\nThe session will also address any additional corporate matters deemed necessary. According to the disclosure, the company’s current board comprises three executive directors (Lim Hou-Sen, Liqiao Ma and Meirong Liu), two non-executive directors (Ao Zhang and Wei Wang) and three independent non-executive directors (Ting Yuk Anthony Wu, Chi Wai Suen and John Junhua Gu).\nThe announcement was authorised for issue by Executive Director Mr Lim Hou-Sen on 19 March 2026 in Hangzhou. No further financial details were provided ahead of the scheduled meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}